Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes. [electronic resource] by
- Zambrowicz, Brian
- Ding, Zhi-Ming
- Ogbaa, Ike
- Frazier, Kenny
- Banks, Phillip
- Turnage, Anne
- Freiman, Joel
- Smith, Melinda
- Ruff, Dennis
- Sands, Arthur
- Powell, David
Producer: 20130829
In:
Clinical therapeutics vol. 35
Availability: No items available.
|
|
17.
|
Corrigendum: Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy. [electronic resource] by
- Ding, Zhi-Ming
- Xiao, Yue
- Wu, Xikun
- Zou, Haixia
- Yang, Shurong
- Shen, Yiyun
- Xu, Juehua
- Workman, Heather C
- Usborne, Amy L
- Hua, Haiqing
Publication details: Frontiers in pharmacology 2020
In:
Frontiers in pharmacology vol. 11
Availability: No items available.
|
|
18.
|
Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy. [electronic resource] by
- Ding, Zhi-Ming
- Xiao, Yue
- Wu, Xikun
- Zou, Haixia
- Yang, Shurong
- Shen, Yiyun
- Xu, Juehua
- Workman, Heather C
- Usborne, Amy L
- Hua, Haiqing
Publication details: Frontiers in pharmacology 2018
In:
Frontiers in pharmacology vol. 9
Availability: No items available.
|
|
19.
|
|
|
20.
|
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. [electronic resource] by
- Powell, David R
- Smith, Melinda
- Greer, Jennifer
- Harris, Angela
- Zhao, Sharon
- DaCosta, Christopher
- Mseeh, Faika
- Shadoan, Melanie K
- Sands, Arthur
- Zambrowicz, Brian
- Ding, Zhi-Ming
Producer: 20130617
In:
The Journal of pharmacology and experimental therapeutics vol. 345
Availability: No items available.
|